
A study on 50 patients with mild to moderate dry eye disease (DED) found that preservative-free Cyclosporine 0.05% (Cyclisis-PF) significantly improved tear film stability, TBUT, NIBUT, Schirmer’s test, and other key markers over 12 weeks. Only 10% reported mild stinging, with no discontinuations. These findings highlight its effectiveness and tolerability as a DED treatment.
Like
Save
Share